Kymera Therapeutics
KYMR
KYMR
121 hedge funds and large institutions have $797M invested in Kymera Therapeutics in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
41% less capital invested
Capital invested by funds: $1.34B → $797M (-$547M)
Holders
121
Holding in Top 10
3
Calls
$680K
Puts
$61K
Top Buyers
| 1 | +$5.21M | |
| 2 | +$2.53M | |
| 3 | +$1.84M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.82M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.72M |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$8.71M | |
| 3 | -$2.91M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.58M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$2.42M |